Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

WHO Approves HPV Vaccine Cervarix For Use In Developing Countries
The World Health Organization has approved GlaxoSmithKline"s human papillomavirus vaccine Cervarix, thus enabling United Nations agencies and partners to officially purchase millions of doses for use in low-income nations, the AP/San Diego Union-Tribune reports (AP/San Diego Union-Tribune, 7/9). Cervarix is highly effective at preventing HPV types 16 and 18, which cause about 70% of cervical cancer cases (GSK release, 7/9). According to the AP/Union-Tribune, more than 80% of the estimated 280,000 cervical cancer deaths annually occur in developing countries.Cervarix has not been approved for use in the U.S. and Japan, but it is available in 97 other countries. FDA is expected to decide in the next few months whether to approve Cervarix for use in the U.S. (AP/San Diego Union-Tribune, 7/9). The agency in 2006 approved Merck"s HPV vaccine Gardasil for girls and women ages nine to 26. Centers for Disease Control and Prevention guidelines recommend routine three-dose vaccination for girls ages 11 and 12 and for girls and women ages 13 to 26 who have not yet been vaccinated (CDC fact sheet, June 2008).The three-shot regimen typically costs about $360. It is unclear if GSK will provide Cervarix at a lower cost to U.N. agencies purchasing it for developing countries (AP/San Diego Union-Tribune, 7/9). GSK said that it is "eager to work with our long-term partner GAVI as well as other private [non-governmental organizations] or governments of developing countries to identify financing mechanisms for the vaccine" (Stovall, Dow Jones, 7/9). The global health association GAVI is a major buyer of vaccines for the developing world. In 2008, GAVI prioritized the purchase of HPV vaccines for the world"s 73 poorest nations. The organization includes U.N. agencies, the World Bank and the Bill and Melinda Gates Foundation (AP/San Diego Union-Tribune, 7/9).
generic viagra online
Nearly Half Of Rheumatoid Arthritis Sufferers Feel Early Treatment Would Have Given Them More Independence
A UK survey of 575 rheumatoid arthritis sufferers highlights the importance of maintaining independence and the significant impact that early diagnosis and treatment can have. Over 94% of those surveyed claimed that their independence was compromised in some way, with over 60% saying it was compromised significantly. With earlier treatment of their disease, nearly half of the respondents felt that they would have been more independent today, making it vital that people are aware of the significance of early intervention. Drugshop to buy zoloft online and other pills.
News of the day
Why Winning Athletes Are Getting Bigger
While watching swimmers line up during the 2008 Olympic Games in Beijing, former Olympic swimmer and NBC Sports commentator Rowdy Gaines quipped that swimmers keep getting bigger, with the shortest one in the current race towering over the average spectator.
Health Insurance

Update Of Radiation Exposure Guidance For The UK

Scientists at the Health Protection Agency have published their advice to UK bodies following new international guidance on ionising radiation*. The International Commission on Radiological Protection (ICRP) published updated recommendations on protection against ionising radiation in 2007. The Health Protection Agency (HPA) has now published its advice on applying those recommendations. Broadly the HPA has welcomed the ICRP"s recommendations and says that much of the advice is already being applied in the UK. After reviewing ICRP guidance, the HPA recommends that the Government tightens control of public radiation exposure at any new build nuclear power stations or radioactive waste disposal sites to a level of less than 0.15 millisieverts (mSv) a year. The average annual dose that a person receives from natural ionising radiation is 2.2 mSv a year. Part of the ICRP report looks at management of, and responses to, radiation emergencies. The HPA has concluded the ICRP"s guidance is helpful and is calling on all appropriate bodies to review their plans on how the aftermath of an incident could be managed. Dr John Cooper, Director of the HPA"s Centre for Radiation, Chemical and Environmental Hazards, said: "ICRP"s recommendations have resulted from extensive international consultation, and in the UK we have also carried out an open consultation. "Mostly there is no need to change UK regulations and procedures, but when these are reviewed in the future, the new recommendations should be implemented as described in our advice". * Application of the 2007 Recommendations of the ICRP to the UK - Advice from the Health Protection Agency. RCE-12. June 2009. ISBN: 978-0-85951-647-1. Available by download from the HPA website: click here. Notes - The International Commission on Radiological Protection published its recommendations in 2007 following extensive consultation. In 2008 the HPA carried out a national consultation on the ICRP"s recommendations, and the feedback received during that process will be published later. - Under the Health Protection Act 2004 which set up the HPA, one of its functions is to advise Government and other interested parties on the application of international recommendations on radiation protection in the UK. - Previous advice from the former National Radiological Protection Board was that public exposure levels at radiation facilities, including new build, should be controlled below a maximum of 0.3mSv. Health Protection Agency


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009